We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Facciola, G, Avenoso, A, Scordo, MG, Madia, AG, Ventimiglia, A, Perucca, E.Small efeets of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit1999;21(3):34l–5.CrossRefGoogle ScholarPubMed
[3]
Kando, JC, Tohen, M, Castillo, J, Centorrino, F.Concurrent use of clozapine and valproate in affective and psychotic disorders. J Clin Psychiatry1994;55:255–7.Google ScholarPubMed
[4]
Kishi, T, Fujita, N, Kawaguchi, H, Ishimae, M, Watanabe, K, Tanaka, T.Bone marrow suppression induced by high dose valproic acid. Arch Dis Child1994;71(2):153–5.CrossRefGoogle ScholarPubMed
[5]
Luchins, DJ.Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine. Am J Psychiatry1984;141(5):687–8.Google Scholar
[6]
MacDougall, LG.Pure red cell aplasia associated with sodium valproate therapy. J Am Med Assoc1982;247(1):53–4.CrossRefGoogle ScholarPubMed
[7]
Watts, RG, Emanuel, PD, Zuckerman, KS, Howard, TH.Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis. J Pediatr1990;117(3):495–9.CrossRefGoogle ScholarPubMed